[Name of Drug] Commercial name: Aganding General name: Adfovir Dipivoxil Tablets [Description] White or offwhite tablets [Indication] Applicable to adult patients with compensated chronic hepatitis B demonstrating the evidence of hepatitis B virus replication, accompanied by continuous increase in serum transaminase (ALT or AST) or histological active lesion in the liver [Application & Dosage] Taken orally ante or post cibum, once a day and 10mg each time for adults. The optimal regimen is undecided. [Specification] 10mg [Storage] Protected from light and preserved in shady, cool (up to 20℃) and dry place, tightly sealed.

[Name of Drug] Commercial name: Enganding General name: Entecavir Capsules [Description] White or almost white granules or powders [Indication] Applicable to adult hepatitis B patients with active virus replication, continuous increase in serum transaminase (ALT) or histological active lesion in the liver. [Application & Dosage] Taken orally on an empty stomach (2h ante or post cibum), once a day, 0.5mg each time for adults and teenagers of 16 years old or above, and 1.0mg each time for patients with viremia in lamivudine treatment. [Specification] 0.5mg [Storage] Protected from light and preserved in dry place under 25℃ below, tightly sealed.

Tenofovir disoproxil fumarate is an inhibitor of nucleotide reverse transcriptase for the treatment of chronic hepatitis B. A number of studies at home and abroad show that tenofovir disoproxil fumarate has strong anti HBV effect and low drug resistance, which is effective for chronic hepatitis B patients who have experienced unsuccessful treatment with a variety of nucleotides. As the most advanced, optimal, effective and safest anti HBV drug at present, tenofovir disoproxil fumarate is recommended as a first-line drug by many guidelines at home and abroad such as guideline of American Association for the Study of Liver Diseases and guideline of European Association for the Study of the Liver, etc.

[Name of Drug] Commercial name: Heganding General name: Lamivudine Tablets [Description] Film coated, white after removing the film coat. [Indication] Applicable to adult patients with compensated chronic hepatitis B, accompanied by continual increase of alanine aminotransferase (ALT) and active virus replication. [Application & Dosage] This product should be used under the direction of experienced doctors in chronical hepatitis B treatment. It is recommended to take once a day, 100mg each time, ante or post cibum. [Specification] 100mg [Storage] Protected from light and preserved in shady, cool and dry place, tightly sealed.